(Q47402954)

15 January 2018

meta-analysis

0 references

title

Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis (English)

1 reference

15 January 2018

1 reference

1 reference

4

1 reference

15 January 2018

Jeffrey Lieberman

6

object named as

Jeffrey A Lieberman

1 reference

15 January 2018

Herbert Y. Meltzer

5

0 references

Clement C. Zai

2

0 references

James L. Kennedy

7

0 references

Daniel J. Müller

8

0 references

Michelle N Sicard

1

object named as

Michelle N Sicard

1 reference

15 January 2018

author name string

Arun K Tiwari

3

1 reference

15 January 2018

Daniel J Müller

8

1 reference

15 January 2018

publication date

1 November 2010

1 reference

15 January 2018

published in

Pharmacogenomics

1 reference

15 January 2018

volume

11

1 reference

15 January 2018

issue

11

1 reference

15 January 2018

page(s)

1561-1571

1 reference

15 January 2018

Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles

cites work

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Antipsychotic induced weight gain in schizophrenia:mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Agonist diversity in 5-HT(2C) receptor-mediated weight control in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Serotonergic control of the organization of feeding and satiety

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Genetics of antipsychotic treatment emergent weight gain in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Clozapine-induced weight gain: a study in monozygotic twins and same-sex sib pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Feeding and stress interact through the serotonin 2C receptor in developing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

The 5-HT2C receptor and antipsychoticinduced weight gain - mechanisms and genetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Molecular biology of 5-HT receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

-759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Olanzapine-induced weight gain is associated with the -759C/T and -697G/C polymorphisms of the HTR2C gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

-759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Genetic variants of the serotonin system and weight change during clozapine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Efficacy and side-effects of clozapine not associated with variation in the 5-HT2C receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

5-HT2C receptor gene polymorphisms associated with antipsychotic drug action alter promoter activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Pedigree disequilibrium tests for multilocus haplotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Modification of human 5-HT(2C) receptor function by Cys23Ser, an abundant, naturally occurring amino-acid substitution.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Pharmacogenetics of antipsychotic-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.123

21 January 2018

Identifiers

DOI

10.2217/PGS.10.123

1 reference

15 January 2018

1 reference

15 January 2018